Home National Georgia Start-Up Gets Federal Funding for Nasal COVID Vaccine Trial

Georgia Start-Up Gets Federal Funding for Nasal COVID Vaccine Trial

by Sonia Park
0 comment
Georgia Start-Up Gets Federal Funding for Nasal COVID Vaccine Trial

A University of Georgia-based start-up, CyanVac LLC, announces it will commence a clinical trial for a nasal COVID-19 vaccine this fall, bolstered by federal funding. The innovative trial is funded by Project NextGen, a federal initiative managed by the U.S. Department of Health and Human Services aimed at advancing next-generation COVID-19 vaccines and treatments.

A University of Georgia-based start-up will launch a nasal COVID vaccine trial this fall. Sara Lee Kessler reports.

The new vaccine utilizes a unique viral delivery platform that incorporates modified strains of canine influenza virus, which. . .

You have exceeded the number of free content views. To continue viewing exclusive JudgeNap content,  you'll need a subscription. Please choose your subscription plan here.

Already a member?  Login here.

You may also like

Our Company

Judge Andrew P. Napolitano – Judging Freedom – JudgeNap.com

Newsletter

Subscribe to the Judging Freedom Newsletter and stay updated!

Laest News

@2023 – All Right Reserved. Designed and Developed by:

 Christopher Leonard – OMG Media Partners, LLC.

-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.